PI
ORTX

Putnam Investments’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Putnam Investments’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-99,489
Closed -$11.8M – 952
2019
Q3 		$11.8M Sell
99,489
-16,126
-14% -$2.25M 0.03% 337
2019
Q2 		$16.2M Buy
115,615
+77,485
+203% +$13.6M 0.04% 280
2019
Q1 		$6.82M Buy
+38,130
New +$5.73M 0.02% 434

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Putnam Investments's ORTX Position: Q4 2019 in Review

Putnam Investments sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 99,489 shares — an estimated $11.8M sold.

Putnam Investments first reported a position in ORTX in Q1 2019 and held it in 3 quarters. The position peaked at $16.2M in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Putnam Investments reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Putnam Investments sold 99,489 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $11.8M.
  • Putnam Investments first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 3 quarters.
  • Putnam Investments's Orchard Therapeutics plc American Depositary Shares position peaked at $16.2M in Q2 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.